Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study.

Trial Profile

Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Mar 2014

At a glance

  • Drugs Zoledronic acid (Primary) ; Antiandrogens
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms ZABTON-PC
  • Most Recent Events

    • 20 Mar 2014 New trial record
    • 01 Feb 2014 Results presented at the 2014 Genitourinary Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top